Jim Olson

I visited this lab when at FDA — lead for pharmaceutical quality, key for investigations of contaminants in drug supply. If this move interrupts agency function, it’s a big deal.

Delighted to speak at Stand up for Science! Bring your kids!

It is important at this pivotal moment to @standupforscience.bsky.social. Looking forward to sharing my thoughts on why this should be a national priority at tomorrow’s rally in SF:

Can I still write "cis" and "trans" in my grant application? Due Monday...

Congratulations to the recipients of the 2025 Damon Runyon-Rachleff Innovation Award! Five exceptional scientists received initial grants, and three previous awardees were given Stage 2 support to continue their critical work. Read more: www.damonrunyon.org/news/entries...

Invent at Seattle Children’s Scholar Profile: Dr. Akinsola Oyelakin YouTube video by Seattle Children's

Meet Akinsola Oyelakin, an Invent@SC scholar who seeks to halt schizophrenia progression. Please share broadly.
#postdoc #academicsky #biotech #jobs #science #therapeutics #biotechsky #SeattleChildren's #UniversityofWashington #FredHutch #BenaroyaResearchInstitute
youtu.be/owOiCEzNmKs

The antidote for despair is action ❤️

* Dial (202) 224-3121
* Enter zip code
* Leave voicemail
* Say “My name is ___, I’m a constituent in [town]. (If clinician/scientist, say so)

“The NIH freeze harms research and patients and must be lifted immediately.”

Be brief. Staffers tally all calls. Go! ✅

Have questions about the 2025 #HannaGrayFellows Program?

Join us for one of our informational webinar to learn more about the application process & what it means to be part of this incredible program:

Wed, 1.23.25 | 3:30–4:30PM ET

Thu, 1.30.25 | 3:30–4:30PM ET

Register today! hhmi.news/40ymhuq

FDA grants accelerated approval to zenocutuzumab-zbco On December 4, 2024, the FDA granted accelerated approval to zenocutuzumab-zbco for non-small cell lung cancer and pancreatic adenocarcinoma.

#FDA grants accelerated approval to HER2/HER3 bispecific ab
#zenocutuzumab for previously treated advanced #NSCLC and #pancreatic cancer and #NRG1 fusion. Thanks to patients, PIs (Ali Schram, Alex Drilon, Jordi Rodon, Eileen O'Reilly, and others) #OncSky #MedSky
www.fda.gov/drugs/resour...

Great team for a great cause! Thanks for investing in the education of next generation scientific leaders!

ASCO annual meeting 2025 abstract submitter open - closes Jan 28th.

To support global innovation in cancer research, payment waivers offered to 1st authors from low- & lower-middle-income countries (World Bank)!

Apply for a waiver when you submit an abstract

conferences.asco.org/am/abstract-...

Welcome Jeff!

Big shout out to our valued colleagues at the #NIH, #FDA, & #CDC. Each person that I've worked with has been smart, hardworking, and committed to the health of our country. While it would be shocking if we agreed with every decision or process, these colleagues have earned and retain my trust.

How to learn about biotech and pharma Since joining Tufts University Department of Biology, I've been helping upper-level biology majors and biology MS/PhD students explore non-academic / non-medical career options. Many them have questio...

I finally compiled my recs for newbies of how to learn about the drug dev biz into a blog post: www.linkedin.com/pulse/how-le...

#Gradstudents new to Bluesky and interested in discovering new therapeutics - please check out Invent@SC #postdoc scholars program. Biotech training & mentors. Salary starts at $80k/year.

ARI0003: Co-transduced CD19/BCMA Dual-targeting CAR-T Cells for the Treatment of Non-Hodgkin Lymphoma Guedan and colleagues demonstrates the potential of BCMA as a cotarget with CD19 for lymphoma treatment. They address challenges of imbalanced CAR expression after cotransduction and demonstrate the s...

The pioneers in Barcelona are at it again: now with point-of-care tandem vectors CD19/BCMA. Local manufacturing drives innovation. This is a really good pre-clinical manuscript for those interested in CAR formats #ASGCT #ASH2024

www.cell.com/molecular-th...

Congrats on your remarkable accomplishments, Sam. Best wishes to the Day One team as they enter the next chapter. #biosky

Sally and I had front row seats to Itzhak Perlman this week. Seeing every micro-emotion on his face as he played was almost as beautiful as his music. Didn't think about politics once for over 3 hours! #arts #music

Interested in discovering novel therapeutics that benefit children? Seattle Children's, UW, Fred Hutch, and Benaroya Research Institute offer postdocs starting at $80K. Please spread the word! #academicsky #blacksky

Encourage #postdocs interested in #biotech to read this article. Some academic centers are trying to fill the de-risking space. Hope these added costs and labor are recognized when companies spin out so that the practice is rewarded enough to be sustainable.

Thanks for encouraging us to move to Bluesky, @drsam.bsky.social. We have complete confidence in your ability to find a few words to share to the #biotech and #drugdevelopment community!

Looking forward to building a strong biotech & academic community on Bluesky. 10 minutes a day...

Venom Helped Create Weight-Loss Drugs. What Else Could It Do For Us? A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the beginning.

First Bluesky post: NYTimes highlights our work on scorpion venom for cancer surgical guidance. www.nytimes.com/2024/11/13/m...